Zofran Use May Cause Birth Defects

Sokolove Law is no longer accepting Zofran cases.

Were you prescribed Zofran (ondansetron) during your pregnancy to ease nausea or morning sickness? If you took this drug, and your child was born with one of several different birth defects, you and your child may be entitled to compensation.

Zofran and Off-Label Prescriptions for Pregnant Women

Zofran was originally developed to help individuals suffering from chemotherapy-induced nausea and vomiting, and has since been labeled for use in nausea/vomiting associated with radiation, surgery, and anesthesia. However, Zofran is not approved by the FDA for treating nausea or vomiting in pregnant women, but doctors may still prescribe the medication “off-label.”

Zofran Birth Defects and Side Effects

Taking Zofran while pregnant may increase the risk of birth defects such as:

  • Cleft lip
  • Cleft palate
  • Club foot
  • Heart/Septal defects (e.g. a hole in the heart)
  • Craniosynostosis (when the joints between the bones of a baby's skull close prematurely, before the brain is fully developed – causing the head to be misshapen and preventing the brain from growing properly.)

An article from the College of Family Physicians of Canada noted that more research needs to be done regarding how Zofran can affect pregnant women and their unborn children, and “based on the data available today, ondansetron use cannot be assumed to be safe during pregnancy.”

Zofran Lawsuits

If your child was born with a birth defect, and you took Zofran while pregnant, you and your child may be entitled to compensation. Contact us today for a free consultation by calling Sokolove Law toll-free, or by filling out the form on this page.

Zofran® is a registered trademark of GlaxoSmithKline, PLC

Note: Do not change medications without first consulting your doctor.

AL - Leila H. Watson, Cory Watson P.C., 2131 Magnolia Ave., Birmingham, AL 35205; provided funding for this advertisement and is responsible for the content. Clients may be jointly represented by Cory Watson P.C. and Sokolove Law.